Search results for CD34 Antibody

APC Anti-CD34 antibody [EP373Y], Abcam, AB310881

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

FITC Anti-CD34 antibody [1H6], Abcam, AB35038

Clone 1H6 is reported for use in CD34+ enrichment studies. Fusion Partners: Spleen cells from immunised BALB/c mice were fused with cells of the mouse NS-1/FOX-NY myeloma cell line.

FITC Anti-CD34 antibody [581], Abcam, AB131589

CD34 antibody [4H11(APG)] (Biotin), Genetex, GTX78339

CD34 antibody [QBEnd/10] (FITC), Genetex, GTX79899

CD34 antibody [QBEnd/10] (PE), Genetex, GTX79900

Anti-CD34 antibody [4H11[APG]], Abcam, AB762

Anti-CD34 antibody [EPR27431-71], Abcam, AB316277

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD34 antibody [EPR27432-54], Abcam, AB315802

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD34 antibody [ICO-115], Abcam, AB187282